| Literature DB >> 32374923 |
Kentaro Ichioka1, Yoshiyuki Matsui1,2, Naoki Terada1,2, Hiromitsu Negoro1,2, Takayuki Goto1,2, Osamu Ogawa2.
Abstract
BACKGROUND: Microdissection testicular sperm extraction (microTESE) is considered the gold standard method of sperm retrieval from patients with non-obstructive azoospermia (NOA). For careful and thorough examination of seminiferous tubules during microTESE, maximizing surface area of the testicles which we are able to search is essential.Entities:
Keywords: TESE; male infertility; microdissection; non-obstructive azoospermia; simulation; testis
Mesh:
Year: 2020 PMID: 32374923 PMCID: PMC7522677 DOI: 10.1111/andr.12812
Source DB: PubMed Journal: Andrology ISSN: 2047-2919 Impact factor: 3.842
Figure 1Mathematical model of the testis, which has an ellipsoid shape with the lengths of each axis denoted as Al, Bl, and Cl, with Al being the longest and Cl the shortest (Al > Bl>Cl). This testis model was placed into the X‐Y‐Z axis with the longitudinal incision parallel to the X‐axis and the coronal and sagittal planes corresponding to the X‐Y and X‐Z planes, respectively
Figure 2Schematic illustrations of (A) a longitudinal incision on the tunica albuginea and transverse slicing incisions in the parenchyma, (B) a longitudinal incision on the tunica albuginea and sagittal incisions in the parenchyma, (C) a transverse incision on the tunica albuginea and sagittal incisions in the parenchyma, and (D) a transverse incision on the tunica albuginea and coronal incisions in the parenchyma. The width of the sliced piece of testicular parenchyma was assumed to be l
Figure 3The method to maximize the surface area in microTESE. (A) A long longitudinal incision was made in the tunica albuginea. (B) After the initial incision, the testis was opened by incision to form a bivalved testis. (C) The tunica albuginea was pushed upward turning the parenchyma inside out. (D) Transverse slicing incisions on the parenchyma provided the maximum surface area in microTESE
Pre‐operative basic characteristics of 158 patients stratified with surgical methods
| Previous method | New method |
| |
|---|---|---|---|
| (2011‐2014) | (2014‐2018) | ||
| Total number of patients | 56 | 102 | |
| Klinefelter syndrome | 8 (14.3%) | 11 (10.8%) | NS |
| AZFc deletion | 0 | 2 (2.0%) | |
| 47XYY | 0 | 2 (2.0%) | |
| Post–anti‐cancer chemotherapy | 4 (7.1%) | 3 (2.9%) | |
| History of cryptorchidism | 3 (5.4%) | 7 (6.9%) | |
| Others | 41 (73.2%) | 77 (75.5%) | |
| Average age (years, range) | 37.0 (27‐51) | 37.0 (26‐61) | NS |
| Average luteinizing hormone (mIU/mL, range) | 8.1 (2.3‐28.2) | 8.0 (1.5‐29.6) | NS |
| Average follicle‐stimulating hormone (mIU/mL, range) | 20.0 (2.9‐55.9) | 21.4 (2.7‐61.9) | NS |
| Average testosterone (ng/mL) | 3.7 (0.4‐12.1) | 4.2 (0.7‐9.6) | NS |
Sperm retrieval rates of the overall and the subgroups classified by etiologies and pathologies of NOA
| Previous method | New method |
| |
|---|---|---|---|
| (2011‐2014) | (2014‐2018) | ||
| Overall successful sperm retrieval | 16/56 (29%) | 46/102 (45%) | <.05 |
| Klinefelter syndrome | 1/8 (12.5%) | 5/11 (45.5%) | NS |
| AZFc deletion | 0/0 | 1/2 (50%) | ‐ |
| 47XYY | 0/0 | 2/2 (100%) | ‐ |
| Post–anti‐cancer chemotherapy | 0/4 (0%) | 0/3 (0%) | ‐ |
| History of cryptorchidism | 3/3 (100%) | 6/7 (85.7%) | NS |
| Others | 12/41 (29.3%) | 32/77 (41.6%) | NS |
| Hypospermatogenesis | 13/24 (54.1%) | 32/44 (72.7%) | NS |
| Uniform maturation arrest | 0/2 (0%) | 8/9 (88.9%) | .011 |
| Sertoli cell only | 3/30 (10%) | 6/49 (12.2%) | NS |
Post‐operative complications of each surgical method
| Previous method | New method |
| |
|---|---|---|---|
| (2011‐2014) | (2014‐2018) | ||
| Hematoma formation | 0 | 0 | NS |
| Wound infection | 0 | 0 | NS |
| Symptoms of androgen deficiency | 0 | 0 | NS |
| Additional use of NSAIDs | 1/56 (1.8%) | 2/102 (2.0%) | NS |